Lucid Financial Statements From 2010 to 2026

Lucid Diagnostics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 24 M 35.3 M 12.5 M Slightly volatile Other Current Liabilities 3.1 M 3.3 M 3.2 M Slightly volatile Total Current Liabilities 13.9 M 27.1 M 8.1 M Slightly volatile Other Liabilities 288.3 K 324.4 K 354.1 K Slightly volatile Accounts Payable 1.3 M 1.4 M 882 K Slightly volatile Cash 18.5 M 25.7 M 9.5 M Slightly volatile Cash And Short Term Investments 18.5 M 25.7 M 9.5 M Slightly volatile Common Stock Shares Outstanding 43.3 M 58.1 M 39.6 M Slightly volatile Liabilities And Stockholders Equity 24 M 35.3 M 12.5 M Slightly volatile Other Stockholder Equity 186.8 M 177.9 M 51 M Slightly volatile Total Liabilities 30.6 M 29.1 M 9.4 M Slightly volatile Total Current Assets 20.5 M 28.9 M 10.6 M Slightly volatile Common Stock 76.1 K 72.5 K 26.3 K Slightly volatile Non Current Assets Total 4 M 6.4 M 2.2 M Slightly volatile Non Currrent Assets Other 1 M 1.3 M 799.5 K Slightly volatile Short Term Investments 1.6 M 1.5 M 561.5 K Slightly volatile Non Current Liabilities Total 984.4 K 1.6 M 1 M Slightly volatile Other Current Assets 1.9 M 2.4 M 981.8 K Slightly volatile Capital Stock 65.8 M 62.7 M 11.9 M Slightly volatile Net Receivables 489 K 465.8 K 95.4 K Slightly volatile Property Plant Equipment 1.4 M 1.8 M 1.2 M Slightly volatile Short and Long Term Debt Total 14.1 M 24.4 M 5.9 M Slightly volatile Common Stock Total Equity 32.8 K 36.9 K 40.3 K Slightly volatile Capital Surpluse 96.9 M 109 M 118.9 M Slightly volatile Non Current Liabilities Other 829.6 K 933.3 K 1 M Slightly volatile Short Term Debt 13 M 22.4 M 4.8 M Slightly volatile Intangible Assets 629.3 K 662.4 K 2.8 M Slightly volatile Current Deferred Revenue 748.8 K 842.4 K 919.5 K Slightly volatile Short and Long Term Debt 17.9 M 21.4 M 14.9 M Slightly volatile Good Will 588.2 M 661.7 M 722.3 M Slightly volatile
Lucid Diagnostics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 997.8 K 1.1 M 2.1 M Very volatile Selling General Administrative 24.3 B 23.2 B 4 B Slightly volatile Selling And Marketing Expenses 19.9 B 18.9 B 3.3 B Slightly volatile Other Operating Expenses 31.5 M 58 M 17.8 M Slightly volatile Research Development 6.9 M 6.9 M 3.7 M Slightly volatile Total Operating Expenses 28.1 M 48.5 M 15.5 M Slightly volatile Interest Income 305.8 K 370.3 K 150.9 K Slightly volatile
Lucid Diagnostics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 5.7 M 5.2 M 2.8 M Slightly volatile Depreciation 882.8 K 1.3 M 463.2 K Slightly volatile Capital Expenditures 498.4 K 581.4 K 725.7 K Slightly volatile Change To Operating Activities 11.1 M 10.5 M 3.3 M Slightly volatile Total Cash From Financing Activities 58.3 M 55.5 M 16.2 M Slightly volatile End Period Cash Flow 18.5 M 25.7 M 9.5 M Slightly volatile Change To Netincome 16.7 M 15.9 M 5.2 M Slightly volatile Begin Period Cash Flow 17.5 M 21.7 M 7.9 M Slightly volatile Sale Purchase Of Stock 405.9 M 514 M 196.2 M Slightly volatile Change Receivables 146.4 K 164.7 K 179.8 K Slightly volatile Cash Flows Other Operating 2.4 M 2.7 M 2.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 10.4 10.94 284 Slightly volatile Days Sales Outstanding 32.14 30.61 18.6761 Slightly volatile Average Payables 1.1 M 1.3 M 1.4 M Slightly volatile Stock Based Compensation To Revenue 1.14 1.2 16.2549 Slightly volatile Capex To Depreciation 0.6 0.64 152 Slightly volatile EV To Sales 10.12 10.65 205 Slightly volatile Inventory Turnover 17.7 21.82 8.2973 Slightly volatile Days Of Inventory On Hand 16.45 17.32 221 Slightly volatile Payables Turnover 3.58 5.99 1.8684 Slightly volatile Sales General And Administrative To Revenue 4.4 K 4.2 K 798 Slightly volatile Research And Ddevelopement To Revenue 1.51 1.59 15.352 Slightly volatile Capex To Revenue 0.16 0.17 1.3921 Slightly volatile Cash Per Share 0.34 0.4 0.2209 Slightly volatile Days Payables Outstanding 59.87 63.02 676 Slightly volatile Income Quality 0.46 0.87 0.3649 Slightly volatile Intangibles To Total Assets 0.0262 0.0276 0.0887 Slightly volatile Current Ratio 0.91 0.96 1.1961 Slightly volatile Receivables Turnover 17.87 9.66 8.4937 Slightly volatile Capex Per Share 0.0107 0.0115 0.0067 Slightly volatile Revenue Per Share 0.0813 0.0774 0.0282 Slightly volatile Interest Debt Per Share 0.4 0.38 0.1089 Slightly volatile Debt To Assets 0.35 0.62 0.1777 Slightly volatile Operating Cycle 53.61 56.43 332 Slightly volatile Days Of Payables Outstanding 59.87 63.02 676 Slightly volatile Ebt Per Ebit 1.13 1.14 1.0423 Slightly volatile Total Debt To Capitalization 0.55 0.72 0.252 Slightly volatile Quick Ratio 0.9 0.95 1.1828 Slightly volatile Cash Ratio 0.81 0.86 1.1004 Slightly volatile Days Of Inventory Outstanding 16.45 17.32 221 Slightly volatile Days Of Sales Outstanding 32.14 30.61 18.6761 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.12 1.17 1.0259 Slightly volatile Fixed Asset Turnover 0.54 1.06 0.587 Slightly volatile Debt Ratio 0.35 0.62 0.1777 Slightly volatile Price Sales Ratio 10.4 10.94 284 Slightly volatile Asset Turnover 0.13 0.1415 0.0355 Slightly volatile
Lucid Diagnostics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 33.1 M 37.2 M 40.6 M Slightly volatile Enterprise Value 32.2 M 36.2 M 39.5 M Slightly volatile

Lucid Fundamental Market Drivers

Lucid Upcoming Events

About Lucid Diagnostics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:

How To Invest In Lucid Details

Is Lucid Stock a good investment? Details

What is Lucid Diagnostics' Net Worth? Details

Largest Health Care Equipment & Supplies Companies View

Largest Health Care Equipment & Services Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details